Nanomedicine Market By Product Type (Liposomal Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Dendrimers, Solid Lipid Nanoparticles (SLNs), Others), By Drug Type (Small Molecule Nanodrugs, Monoclonal Antibody-Conjugated Nanoparticles, mRNA-based Nanomedicines, Peptide Nanomedicines, siRNA-loaded Nanocarriers), By Nanotechnology Type (Nanoparticles, Nanotubes, Nanoshells, Nanocapsules, Quantum Dots, Nanomicelles), By Mechanism of Action (Passive Targeting, Active Targeting, Controlled Release Systems, Magnetically Guided Delivery, Photothermal Therapy, Photodynamic Therapy), By Indication (Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Ophthalmic Disorders), By Application (Targeted Drug Delivery, Cancer Therapy, In-vivo Imaging, Regenerative Medicine, Theranostics, Personalized Nanomedicine, mRNA Vaccines & Delivery, Others), By End-user (Hospitals & Specialty Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations (CROs), Diagnostic Laboratories, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025–2035

---

Report Coverage:

By Product Type

• Liposomal Nanoparticles
• Polymeric Nanoparticles
• Metallic Nanoparticles
• Dendrimers
• Solid Lipid Nanoparticles (SLNs)
• Others

By Drug Type

• Small Molecule Nanodrugs
• Monoclonal Antibody-Conjugated Nanoparticles
• mRNA-based Nanomedicines
• Peptide Nanomedicines
• siRNA-loaded Nanocarriers

By Nanotechnology Type

• Nanoparticles
• Nanotubes
• Nanoshells
• Nanocapsules
• Quantum Dots
• Nanomicelles

By Mechanism of Action

• Passive Targeting
• Active Targeting
• Controlled Release Systems
• Magnetically Guided Delivery
• Photothermal Therapy
• Photodynamic Therapy

By Indication

• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Ophthalmic Disorders

By Application

• Targeted Drug Delivery
• Cancer Therapy
• In-vivo Imaging
• Regenerative Medicine
• Theranostics
• Personalized Nanomedicine
• mRNA Vaccines & Delivery
• Others

By End User

• Hospitals & Specialty Clinics
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Contract Research Organizations (CROs)
• Diagnostic Laboratories
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Switzerland
• Sweden
• Finland
• Netherland
• Poland
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Indonesia
• Malaysia
• Philippines
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Moderna, Inc.
• F. Hoffmann-La Roche Ltd.
• Sanofi S.A.
• Merck & Co., Inc.
• AbbVie Inc.
• Novartis International AG
• AstraZeneca plc
• Celgene Corporation
• Clene Nanomedicine, Inc.
• Nanobiotix S.A.
• BlueWillow Biologics, Inc.
• Acuitas Therapeutics, Inc.
• Camurus AB